TP53 gene mutations in plasma DNA of cancer patients

被引:0
|
作者
Silva, JM [1 ]
Gonzalez, R [1 ]
Dominguez, G [1 ]
Garcia, JM [1 ]
España, P [1 ]
Bonilla, F [1 ]
机构
[1] Clin Puerta de Hierro, Dept Med Oncol, Madrid 28035, Spain
来源
GENES CHROMOSOMES & CANCER | 1999年 / 24卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using different molecular techniques, DNA has been shown to be present in plasma of patients with several types of tumors. Mutations of TP53 are the most common genetic changes in human cancers. We investigated the presence of TP53 gene mutations in plasma DNA of breast and small cell lung cancer patients. Tumor and plasma DNA of 25 patients were studied by PCR-SSCP and direct sequencing, through exons 5, 6, 7, and 8, of TP53. Six cases of mutations in tumor DNA were observed that, in 3 cases (50%), were also identified in plasma of the same patients. Mutations of the TP53 gene are seen in plasma DNA of cancer patients, and may prove to be a useful new tool in the management of these patients. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:160 / 161
页数:2
相关论文
共 50 条
  • [21] TP53 mutations in head and neck cancer
    Nathan, Cherie-Ann
    Khandelwal, Alok R.
    Wolf, Gregory T.
    Rodrigo, Juan P.
    Makitie, Antti A.
    Saba, Nabil F.
    Forastiere, Arlene A.
    Bradford, Carol R.
    Ferlito, Alfio
    MOLECULAR CARCINOGENESIS, 2022, 61 (04) : 385 - 391
  • [22] Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
    Li, Xuerui
    Chen, Xiaoqing
    Wen, Lingzhu
    Wang, Yulei
    Chen, Bo
    Xue, Yunlian
    Guo, Liping
    Liao, Ning
    THORACIC CANCER, 2020, 11 (07) : 1861 - 1868
  • [23] Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients
    Damien Vasseur
    Ahmadreza Arbab
    Fabiola Giudici
    Christophe Marzac
    Stefan Michiels
    Marco Tagliamento
    Arnaud Bayle
    Cristina Smolenschi
    Madona Sakkal
    Mihaela Aldea
    Hela Sassi
    Filippo Gustavo Dall’Olio
    Noémie Pata-Merci
    Sophie Cotteret
    Alice Fiévet
    Nathalie Auger
    Luc Friboulet
    Francesco Facchinetti
    Arthur Géraud
    Santiago Ponce
    Antoine Hollebecque
    Benjamin Besse
    Jean Baptiste Micol
    Antoine Italiano
    Ludovic Lacroix
    Etienne Rouleau
    npj Precision Oncology, 8
  • [24] Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients
    Vasseur, Damien
    Arbab, Ahmadreza
    Giudici, Fabiola
    Marzac, Christophe
    Michiels, Stefan
    Tagliamento, Marco
    Bayle, Arnaud
    Smolenschi, Cristina
    Sakkal, Madona
    Aldea, Mihaela
    Sassi, Hela
    Dall'Olio, Filippo Gustavo
    Pata-Merci, Noemie
    Cotteret, Sophie
    Fievet, Alice
    Auger, Nathalie
    Friboulet, Luc
    Facchinetti, Francesco
    Geraud, Arthur
    Ponce, Santiago
    Hollebecque, Antoine
    Besse, Benjamin
    Micol, Jean Baptiste
    Italiano, Antoine
    Lacroix, Ludovic
    Rouleau, Etienne
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [25] Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
    Barekati, Zeinab
    Radpour, Ramin
    Kohler, Corina
    Zhang, Bei
    Toniolo, Paolo
    Lenner, Per
    Lv, Qing
    Zheng, Hong
    Zhong, Xiao Yan
    HUMAN MOLECULAR GENETICS, 2010, 19 (15) : 2936 - 2946
  • [26] Comparative Analysis of Gene Correlation Networks of Breast Cancer Patients Based on Mutations in TP53
    Park, Byungkyu
    Im, Jinho
    Han, Kyungsook
    BIOMOLECULES, 2022, 12 (07)
  • [27] Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
    Alyami, Hassan
    Yoo, Tae Kyung
    Cheun, Jong Ho
    Lee, Han Byoel
    Jung, Sung Mi
    Ryu, Jai Min
    Bae, Soong June
    Jeong, Joon
    Yoon, Chang Ik
    Ahn, Juneyoung
    Paik, Pill Sun
    Cho, Min Kyung
    Park, Woo Chan
    JOURNAL OF BREAST CANCER, 2021, 24 (02) : 175 - 182
  • [28] Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients
    Olivier, M
    Langerod, A
    Carrieri, P
    Bergh, J
    Klaar, S
    Eyfjord, J
    Theillet, C
    Rodriguez, C
    Lidereau, R
    Bièche, I
    Varley, J
    Bignon, Y
    Uhrhammer, N
    Winqvist, R
    Jukkola-Vuorinen, A
    Niederacher, D
    Kato, S
    Ishioka, C
    Hainaut, P
    Borresen-Dale, AL
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [29] TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients
    Pandey, Ritu
    Johnson, Nathan
    Cooke, Laurence
    Johnson, Benny
    Chen, Yuliang
    Pandey, Manjari
    Chandler, Jason
    Mahadevan, Daruka
    CANCERS, 2021, 13 (04) : 1 - 21
  • [30] KRAS, BRAF and TP53 mutations in Romanian colorectal cancer patients
    Murarasu, Daniela
    Puiu, Liliana
    Mihalcea, Corina
    Cinca, Sabin
    Simion, Laurentiu
    JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S92 - S92